Prof. Mike Carrier published “A Simple Solution to the Problem of ‘Product Hopping’” in the Harvard Health Policy Review.

The piece explains why legislation addressing product hopping, in which brand-name drug companies switch from one version of a drug to another just to keep the generic off the market, is the best option to address this anticompetitive behavior.